Detalles de la búsqueda
1.
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Br J Cancer
; 130(7): 1131-1140, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287179
2.
Practical implementation of the partial ordering continual reassessment method in a Phase I combination-schedule dose-finding trial.
Stat Med
; 41(30): 5789-5809, 2022 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428217
3.
Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumors.
Cancer Sci
; 109(10): 3253-3262, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30099818
4.
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
Invest New Drugs
; 31(5): 1207-16, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23397499
5.
First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study.
Lancet Oncol
; 12(1): 30-7, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21169060
6.
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer.
Lung Cancer
; 163: 19-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894455
7.
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer.
NPJ Breast Cancer
; 8(1): 45, 2022 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35393425
8.
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Lancet
; 373(9674): 1525-31, 2009 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19410716
9.
Simple-to-use, reference criteria for revealing drug-induced QT interval prolongation in conscious dogs.
Eur J Pharmacol
; 554(1): 46-52, 2007 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17112506
Resultados
1 -
9
de 9
1
Próxima >
>>